Elanco Animal Health Inc Stockholders Equity

Quick Answer

Elanco Animal Health Inc reported Stockholders Equity of $6.55 billion for fiscal year 2025.

Elanco Animal Health Inc Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $6.55B +7.4%
2024 $6.10B -2.0%
2023 $6.22B -14.6%
2022 $7.29B -2.9%
2021 $7.51B -11.2%
2020 $8.46B +52.6%
2019 $5.54B +6.7%
2018 $5.20B -33.2%
2017 $7.78B +10.9%
2016 $7.02B -5.5%
2015 $7.43B

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $6.75B +3.5% -0.4%
June 30, 2025 $6.78B +14.0% +6.6%
March 31, 2025 $6.35B +4.9% +4.2%
December 31, 2024 $6.10B -2.0% -6.5%
September 30, 2024 $6.52B +6.3% +9.8%
June 30, 2024 $5.94B -19.9% -1.9%
March 31, 2024 $6.06B -19.0% -2.7%
December 31, 2023 $6.22B -14.6% +1.5%
  • Elanco Animal Health Inc showed an increase of +7.4% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2015–2025 period, Elanco Animal Health Inc’s stockholders equity has declined by 11.9% (from $7.43 billion to $6.55 billion).
  • The most recent figure is from Elanco Animal Health Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment